AINOSTICS Company
The Sixth Sense in medical Diagnostics. At AINOSTICS we are working to identify the earliest biological signs of some of our societyвАЩs most devastating neurodegenerative conditions such as AlzheimerвАЩs disease, Huntington's and MS, providing the best chance of success in the development of potential preventions and therapeutics by Pharma, and precise treatment planning by clinicians. We combine the most exciting medical imaging innovations with the best of artificial intelligence solutions to unlock the future of personalised diagnosis, prognosis, and therapy monitoring and planning.
Last Funding Type:
Grant
Headquarters:
Manchester, Manchester, United Kingdom
Founded Date:
2018-06-18
Last Funding Date:
2022-02-07
Total Funding:
6500000
Employee Number:
11-50
Investors Number:
1
Industry:
Neurodegeneration and Aging